| Literature DB >> 30738129 |
Haiyu Ni1, Shuwen Xu1, Pengfei Gu1, Adelijiang Wusiman1, Yue Zhang1, Tianxin Qiu1, Zhenguang Liu1, Han Ni1, Yuanliang Hu1, Jiaguo Liu1, Yi Wu1, Deyun Wang2.
Abstract
This study aimed to optimize the preparation conditions for cetyltrimethylammonium bromide-modified Polygonatum sibiricum polysaccharide cubosomes (CTAB-modified PSP-Cubs) by response surface methodology (RSM). Glyceryl-monooleate (GMO) was used as the lipid base for the cubosomes. The optimal preparation conditions of CTAB-modified PSP-Cubs were as follows: the mass percentage of PSP to GMO (X1), Poloxamer 407 (F127) to GMO (X2) and water to GMO (X3) was 1.4%, 9% and 50%, respectively. The encapsulation efficiency (EE) of CTAB-modified PSP-Cubs under the experimental conditions was 62.4 ± 3.6%, which was close to our predicted value. The particle size, polydispersity index (PDI) and zeta potential of CTAB-modified PSP-Cubs were 427.7 ± 8.0 nm, 0.236 ± 0.024 and 19.2 ± 0.4 mV, respectively. Specific modifications were able to slow down in vitro release behaviors and reduce cytotoxicity to some extent. The effects of CTAB-modified PSP-Cubs on splenic lymphocytes were also investigated. When splenic lymphocytes were treated with CTAB-modified PSP-Cubs together with LPS or PHA, the results showed more favorable effects on cellular proliferation than blank cubosomes or free PSP at certain concentrations.Entities:
Keywords: Cubosomes; Lymphocyte proliferation; Modification; Optimization; Polygonatum sibiricum polysaccharides
Mesh:
Substances:
Year: 2019 PMID: 30738129 DOI: 10.1016/j.ijpharm.2019.01.060
Source DB: PubMed Journal: Int J Pharm ISSN: 0378-5173 Impact factor: 5.875